Covidien , a leading global provider of healthcare products, announced the availability of Covidien Imaging Solutions' contrast delivery system with radio-frequency identification (RFID) technology. The components integrate RFID technology to create a system that is designed to aid in patient safety by helping to reduce the risk of medical errors in radiology departments.
Covidien , a leading global provider of healthcare products, announced the availability of Covidien Imaging Solutions' contrast delivery system with radio-frequency identification (RFID) technology. The components integrate RFID technology to create a system that is designed to aid in patient safety by helping to reduce the risk of medical errors in radiology departments.
Covidien's contrast delivery system combines its unit-dose RFID-enabled Ultraject(TM) prefilled contrast media syringes with its RFID-enabled Optivantage(TM) DH power injector to provide the only contrast delivery solution of its type available in North America. RFID is an automatic identification technology that captures, stores and transmits data between the RFID-enabled Ultraject prefilled syringe and the RFID-enabled Optivantage DH power injector using devices called RFID transponders, or tags.
Steve Hanley, President, Imaging Solutions, Covidien said, Covidien's new, innovative system has the potential to help reduce medical errors and increase efficiency in CT imaging. We expect this technology to be the platform for future innovation
As the pioneer in prefilled syringes for contrast imaging, Covidien has assisted medical professionals by giving them tools to help reduce the risk of certain medication-dispensing and mislabeling errors that may occur when syringes are manually filled from multi-dose packaging.
Hanley added, Risk reduction is one of the key challenges facing the radiology community. Our new delivery system underscores Covidien's commitment to helping our customers address safety-related concerns — we want to give them not just technology, but solutions.
